The genetics of the alternative pathway of complement in the pathogenesis of HELLP syndrome

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 11, 2012, Pages 2322-2325

  Crovetto, Francesca ^a,b   Borsa, Nicolò ^a   Acaia, Barbara ^a   Nishimura, Carla ^c   Frees, Kathy ^c   Smith, Richard J H ^c   Peyvandi, Flora ^b   Palla, Roberta ^b   Cugno, Massimo ^b   Tedeschi, Silvana ^a   Castorina, Pierangela ^a   Somigliana, Edgardo ^a   Ardissino, Gianluigi ^a   Fedele, Luigi ^a,b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Complement; Genetics; HELLP syndrome

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; MEMBRANE COFACTOR PROTEIN;

ADULT; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE GENE; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT COMPONENT C3 GENE; COMPLEMENT FACTOR H GENE; COMPLEMENT FACTOR I GENE; EXON; FEMALE; GENE; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GESTATIONAL AGE; HELLP SYNDROME; HETEROZYGOTE DETECTION; HUMAN; INDUCED ABORTION; INTRON; MEMBRANE COFACTOR PROTEIN GENE; MOLECULAR PATHOLOGY; MULTIPLE MALFORMATION SYNDROME; NUCLEOTIDE SEQUENCE; PREMATURITY; PRIORITY JOURNAL; STILLBIRTH; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGE OF ONSET; ANTIGENS, CD46; COMPLEMENT FACTOR I; COMPLEMENT PATHWAY, ALTERNATIVE; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GESTATIONAL AGE; HELLP SYNDROME; HUMANS; INFANT, NEWBORN; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; RETROSPECTIVE STUDIES;

EID: 84867566240     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.694923     Document Type: Article

References (19)

1. Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA. Liver disease in pregnancy. Lancet 2010;375:594-605.
2. Egerman RS, Sibai BM. HELLP syndrome. Clin Obstet Gynecol 1999;42:381-389. (Pubitemid 30017305)
3. Fang CJ, Richards A, Liszewski MK, Kavanagh D, Atkinson J P. Advances in understanding of pathogenesis of aHUS and HELLP. Br J Haematol 2008;143:336-348.
4. Fakhouri F, Roumenina L, Provot F, Sallée M, Caillard S, Couzi L, Essig M, et al. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol 2010;21:859-867.
5. Lattuada A, Rossi E, Calzarossa C, Candolfi R, Mannucci PM. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome. Haematologica 2003;88:1029-1034. (Pubitemid 37151154)
6. Fakhouri F, Jablonski M, Lepercq J, Blouin J, Benachi A, Hourmant M, Pirson Y, et al. Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome. Blood 2008;112:4542-4545.
7. Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol 2005;16:1035-1050. (Pubitemid 41710314)
8. Loirat C, Noris M, Fremeaux-Bacchi V. Complement and the atypical hemolytic uremic syndrome in children. Pediatr Nephrol 2008;23:1957-1972.
9. Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 2006;195:914-934. (Pubitemid 44415627)
10. Larsson A, Palm M, Hansson LO, Axelsson O. Reference values for clinical chemistry tests during normal pregnancy. BJOG 2008;115:874-881. (Pubitemid 351692991)
11. Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum Mutat 2010;31:E1445-E1460.
12. Nilsson SC, Karpman D, Vaziri-Sani F, Kristoffersson AC, Salomon R, Provot F, Fremeaux-Bacchi V, et al. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Mol Immunol 2007;44:1835-1844.
13. Sibai BM, Ramadan MK. Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am J Obstet Gynecol 1993;168:1682-7; discussion 1687.
14. Abraham KA, Connolly G, Farrell J, Walshe JJ. The HELLP syndrome, a prospective study. Ren Fail 2001;23:705-713. (Pubitemid 33055242)
15. Zheng XL, Sadler JE. Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol 2008;3:249-277. (Pubitemid 351488282)
16. Gul A, Aslan H, Cebeci A, Polat I, Ulusoy S, Ceylan Y. Maternal and fetal outcomes in HELLP syndrome complicated with acute renal failure. Ren Fail 2004;26:557-562. (Pubitemid 39363288)
17. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004;103:981-991. (Pubitemid 40459001)
18. Aslan H, Gul A, Cebeci A. Neonatal outcome in pregnancies after preterm delivery for HELLP syndrome. Gynecol Obstet Invest 2004;58:96-99. (Pubitemid 39140393)
19. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy and Childbirth 2009;26:9-18.